Fluorescence Guided Surgery Systems Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
Description
Fluorescence Guided Surgery Systems Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
The global fluorescence guided surgery systems market reached a valuation of USD 101.3 million in 2023 and is projected to grow at a CAGR of 14.1% from 2024 to 2032. FGS systems enhance surgical procedures by providing real-time imaging that differentiates tissues with fluorescent dyes, supporting more precise and effective surgeries.
Government initiatives focused on enhancing surgical infrastructure are driving significant demand for fluorescence-guided surgery (FGS) systems. These initiatives typically involve investments in advanced medical technologies, facility upgrades, and encouraging the use of innovative tools that improve surgical precision and outcomes. The grant supports OnLume's development of its FGS system, aiming to refine the device for improved intraoperative visualization of blood vessels and small lymphatic tissues, ultimately enhancing surgical accuracy and patient results.
The market is categorized by type into VS3 Iridium systems, SPY systems, PDE systems, and others. In 2023, the SPY system segment led with a market share of 38.1% and is expected to grow at a 15% CAGR. Known for its advanced imaging and precision, the SPY system uses ICG fluorescence imaging to visualize blood flow and tissue perfusion essential for enhancing surgical accuracy by enabling surgeons to assess tissue viability and make informed decisions in real-time.
In terms of application, the market is divided into laparoscopic/endoscopic surgery and open surgery. Open surgery held the largest share in 2023 at 54.2%, largely due to its role in complex, extensive procedures. FGS systems are particularly beneficial in open surgeries, where they enable detailed visualization of tumors and adjacent tissues, facilitating precise removal of malignant cells and minimizing the risk of residual disease.
The U.S. dominated the North American FGS market, generating USD 38.4 million in revenue in 2023. As a hub for medical technology innovation, the U.S. leads in growth of FGS systems with advanced imaging and new fluorescent agents. The high prevalence of cancer further drives demand for FGS, as surgeons prioritize techniques that enhance outcomes in challenging surgeries.
Table of Contents
114 Pages
- Chapter 1 Methodology
- 1.1 Market segmentation
- 1.2 Market definitions
- 1.3 Research design
- 1.4 Market size estimates and calculations
- 1.4.1 Approach 1: Company share analysis
- 1.4.2 Approach 2: Demand-side modelling approach
- 1.5 Key trends for market estimates
- 1.6 Forecast model
- 1.7 Primary research & validation
- 1.7.1 Primary sources
- 1.7.2 Data mining sources
- 1.7.2.1 Paid sources
- 1.7.2.2 Public sources
- Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
- 2.1.1 Business trends
- 2.1.2 Type trends
- 2.1.3 Surgery trends
- 2.1.4 Application trends
- 2.1.5 End-use trends
- 2.1.6 Regional trends
- Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing prevalence of chronic diseases
- 3.2.1.2 Growth in targeted surgeries for cancer and cardiovascular disorders
- 3.2.1.3 Growing focus towards improving surgical outcomes and reducing operating time
- 3.2.1.4 Government initiatives aimed at improving surgical infrastructure
- 3.2.2 Industry pitfalls
- 3.2.2.2 Limited reimbursement coverage for fluorescence imaging procedures
- 3.3 Growth potential analysis
- 3.3.1 By type
- 3.3.2 By surgery
- 3.3.3 By application
- 3.3.4 By end-use
- 3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.1.1 U.S.
- 3.4.1.2 Canada (Health Canada):
- 3.5 North America & Europe Fluorescence guided surgery systems market for oncology centers, by type, 2021 - 2032 ($ Mn)
- 3.5.1 North America
- 3.5.2 Europe
- 3.6 Porter's analysis
- 3.7 PESTEL analysis
- Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.1.1 Stryker Corporation
- 4.1.2 Hamamatsu Photonics K.K.
- 4.1.3 Medtronic plc
- 4.2 Company market share analysis, 2023
- 4.2.1 Global fluorescence guided surgery systems market
- 4.2.2 North America fluorescence guided surgery systems market for Oncology centers
- 4.2.3 Europe fluorescence guided surgery systems market for Oncology centers
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix, 2023
- 4.6 Strategic dashboard
- Chapter 5 Fluorescence Guided Surgery Systems (FGS) Market, By Type
- 5.1 SPY system
- 5.2 Photo Dynamic Eye (PDE) system
- 5.3 VS3 iridium system
- 5.4 Other types
- Chapter 6 Fluorescence Guided Surgery Systems (FGS) Market, By Surgery
- 6.1 Open surgery
- 6.2 Laparoscopic/endoscopic surgery
- Chapter 7 Fluorescence Guided Surgery Systems (FGS) Market, By Application
- 7.1 Cancer surgeries
- 7.2 Cardiovascular surgeries
- 7.3 Other applications
- Chapter 8 Fluorescence Guided Surgery Systems (FGS) Market, By End-use
- 8.1 Hospitals and clinics
- 8.2 Ambulatory surgery centers
- 8.3 Oncology centers
- 8.4 Other end-users
- Chapter 9 Fluorescence Guided Surgery Systems (FGS) Market, By Region
- 9.1 North America
- 9.2 Europe
- 9.3 Asia Pacific
- 9.4 Latin America
- 9.5 Middle East and Africa
- Chapter 10 Company Profiles
- 10.1 B. Braun SE
- 10.1.1 Global overview
- 10.1.2 Business overview
- 10.1.3 Financial data
- 10.1.3.1 Annual sales revenue, 2020-2023 (USD Million)
- 10.1.4 Product landscape
- 10.1.5 Strategic outlook
- 10.1.6 SWOT analysis
- 10.2 Carl Zeiss AG
- 10.2.1 Global overview
- 10.2.2 Business overview
- 10.2.3 Financial data
- 10.2.3.1 Annual sales revenue, 2020-2023 (USD Million)
- 10.2.4 Product landscape
- 10.2.5 SWOT analysis
- 10.3 Danaher Corporation
- 10.3.1 Global overview
- 10.3.2 Business overview
- 10.3.3 Financial data
- 10.3.3.1 Annual sales revenue, 2020-2023 (USD Million)
- 10.3.4 Product landscape
- 10.3.5 Strategic outlook
- 10.3.6 SWOT analysis
- 10.4 Getinge AB
- 10.4.1 Global overview
- 10.4.2 Business overview
- 10.4.3 Financial data
- 10.4.3.1 Annual sales revenue, 2020-2023 (USD Million)
- 10.4.4 Product landscape
- 10.4.5 Strategic outlook
- 10.4.6 SWOT analysis
- 10.5 Hamamatsu Photonics K.K.
- 10.5.1 Global overview
- 10.5.2 Business overview
- 10.5.3 Financial data
- 10.5.3.1 Annual sales revenue, 2020-2023 (USD Million)
- 10.5.4 Product landscape
- 10.5.5 Strategic outlook
- 10.5.6 SWOT analysis
- 10.6 Intuitive Surgical, Inc.
- 10.6.1 Global overview
- 10.6.2 Business overview
- 10.6.3 Financial data
- 10.6.3.1 Annual sales revenue, 2020-2023 (USD Million)
- 10.6.4 Product landscape
- 10.6.5 SWOT analysis
- 10.7 KARL STORZ SE & Co. KG
- 10.7.1 Global overview
- 10.7.2 Business overview
- 10.7.3 Financial data
- 10.7.4 Product landscape
- 10.7.5 Strategic outlook
- 10.7.6 SWOT analysis
- 10.8 Medtronic plc
- 10.8.1 Global overview
- 10.8.2 Business overview
- 10.8.3 Financial data
- 10.8.3.1 Annual sales revenue, 2020-2023 (USD Million)
- 10.8.4 Product landscape
- 10.8.5 SWOT analysis
- 10.9 Olympus Corporation
- 10.9.1 Global overview
- 10.9.2 Business overview
- 10.9.1 Financial data
- 10.9.1.1 Annual sales revenue, 2020-2023 (USD Million)
- 10.9.2 Product landscape
- 10.9.3 Strategic outlook
- 10.9.4 SWOT analysis
- 10.10 OnLume Inc.
- 10.10.1 Global overview
- 10.10.2 Business overview
- 10.10.3 Financial data
- 10.10.4 Product landscape
- 10.10.5 Strategic outlook
- 10.10.6 SWOT analysis
- 10.11 Shimadzu Corporation
- 10.11.1 Global overview
- 10.11.2 Business overview
- 10.11.3 Financial data
- 10.11.3.1 Annual sales revenue, 2020-2023 (USD Million)
- 10.11.4 Product landscape
- 10.11.5 SWOT analysis
- 10.12 Stryker Corporation
- 10.12.1 Global overview
- 10.12.2 Business overview
- 10.12.3 Financial data
- 10.12.3.1 Annual sales revenue, 2020-2023 (USD Million)
- 10.12.4 Product landscape
- 10.12.5 Strategic outlook
- 10.12.6 SWOT analysis
- 10.13 Samvardhana Motherson International Limited
- 10.13.1 Global overview
- 10.13.2 Business overview
- 10.13.3 Financial data
- 10.13.3.1 Annual sales revenue, 2020-2023 (USD Million)
- 10.13.4 Product landscape
- 10.13.5 Strategic outlook
- 10.13.6 SWOT analysis
- 10.14 Sumitomo Mitsui Financial Group, Inc.
- 10.14.1 Global overview
- 10.14.2 Business overview
- 10.14.3 Financial data
- 10.14.3.1 Annual sales revenue, 2020-2023 (USD Million)
- 10.14.4 Product landscape
- 10.14.5 SWOT analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


